TRT Clinics Are Selling You Hormonal Chaos

The liver converts IGF-1 in response to growth hormone signals, but it cannot do that job properly without estrogen present to sensitize the process. That is not a minor detail. That is the whole mechanism these clinics are breaking while charging you to fix what they broke.

Here is the full chain so you can see how this works before we look at where it falls apart.

Your pituitary gland releases growth hormone in pulses, mostly at night during deep sleep. That growth hormone travels to the liver, and the liver responds by producing something called IGF-1, which stands for insulin-like growth factor 1, and what it actually does is carry out most of the tissue-building and recovery effects that people associate with growth hormone itself. Growth hormone is the signal. IGF-1 is the worker who shows up to do the job.

For the liver to respond to that signal properly, estrogen has to be present at adequate levels. Estrogen acts on liver receptors to upregulate the sensitivity of the whole system, meaning the liver becomes more responsive to the growth hormone pulse and produces more IGF-1 as a result. Without enough estrogen, the liver hears the signal but turns down the volume on its own response.

Now here is where testosterone enters the picture, and where the TRT clinic model starts to collapse on itself.

When you give a man exogenous testosterone, some of that testosterone converts into estrogen through a process called aromatization. This is completely normal and is part of how testosterone produces many of its effects in men. Estrogen in men is not a problem to be eliminated. It is a co-signal that makes the whole hormonal system function.

But the standard TRT clinic protocol treats rising estrogen as a problem the moment it shows up on a lab panel. So they prescribe something called anastrozole, which is an aromatase inhibitor, and what it does is block the enzyme responsible for converting testosterone into estrogen. Estrogen levels drop. The clinic calls this optimized.

What actually happened is that you just removed the signal the liver needs to produce IGF-1 efficiently.

So now your testosterone is high, which looks good on paper. Your estrogen is suppressed, which the clinic told you was the goal. And your IGF-1 is low, because the liver lost the estrogen signal it needed to respond to growth hormone properly. You feel flat, your recovery is poor, your body composition is not improving the way you expected, and you go back to the clinic and tell them something feels off.

This is where the peptide sale happens.

The clinic looks at your IGF-1 and sees it is low. Instead of connecting that low IGF-1 to the anastrozole they prescribed, they tell you that you need exogenous IGF-1 or a peptide protocol designed to raise it. They have diagnosed a problem they created, and they are now selling you the solution to that problem at a significant markup.

This is not speculation about motive. The mechanism is straightforward enough that any clinician who understands the estrogen-liver-IGF-1 relationship should recognize what is happening the moment they see suppressed estrogen alongside low IGF-1 in a man on testosterone therapy. Either they do not know the mechanism, which means they should not be prescribing these compounds, or they know it and are selling the downstream fix anyway because it adds revenue. There is no third option that makes the protocol look like good medicine.

The actual guidelines for prescribing exogenous IGF-1 in medical care are narrow to the point of being almost theoretical in a standard clinical setting. The accepted use case involves a condition where the pituitary gland fails to produce adequate growth hormone at all, which is rare, and even in those cases the prescribing pathway involves documented growth hormone deficiency confirmed through provocative testing, not just a low IGF-1 reading on a standard panel. The condition where IGF-1 supplementation is medically indicated in a man with a functioning pituitary, adequate growth hormone output, and an intact liver is not a real condition. It is an artifact of suppressing estrogen with a drug that should not have been prescribed in the first place.

The fix, if you are in this situation, is not more compounds. The fix is removing the one that broke the system.

Most men on testosterone therapy do not need an aromatase inhibitor. The research on this is fairly consistent. Estrogen management through anastrozole is appropriate in a narrow subset of cases where estrogen rises high enough to cause genuine symptoms like significant water retention or gynecomastia that are confirmed to be estrogen-driven and not responsive to dose adjustment. For most men, the right response to rising estrogen on TRT is either adjusting the testosterone dose downward or changing the injection frequency to flatten the peaks that drive aromatization. A smaller, more frequent dose produces a steadier testosterone level with less peak-driven conversion to estrogen, and the liver maintains its IGF-1 production because the estrogen signal stays intact.

If your clinic's default response to any estrogen reading above the bottom of the reference range is to prescribe anastrozole, that is not optimization. That is a protocol designed around a misunderstanding of how the male hormonal system works, or around a business model that benefits from creating deficiencies it can then sell you products to address.

The deeper issue is that testosterone, estrogen, growth hormone, and IGF-1 are not independent levers you can push and pull in isolation. They are a connected system where pulling one lever changes the output of several others. Treating each lab value as a separate problem to be fixed with a separate compound is not precision medicine. It is interference stacked on top of interference, and each additional compound adds its own downstream effects that will eventually show up as new symptoms requiring new interventions.

You are not deficient in IGF-1. You are deficient in the estrogen that your liver needed to make it.

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness